Melissa Hewitt, NP
Gerontology · Alexandria, VANPI 1194242610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $189 and has fallen 87.3% since, to $24 in 2024.
Across 21 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$94
- Johnson & Johnson$76
- Boston Scientific$53
- Novo Nordisk$51
- Lilly USA, LLC$44
- Amgen$28
- plus $87 from 5 others
What the payments were for
- Food & beverage$432100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $94 |
| Johnson & Johnson | 4 | $76 |
| Boston Scientific | 2 | $53 |
| Novo Nordisk | 3 | $51 |
| Lilly USA, LLC | 2 | $44 |
| Amgen | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Novartis | 1 | $18 |
| Astellas Pharma US Inc | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
How this compares
$432 in reported general payments places this provider in the 55th percentile of 130 gerontology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 43 | $727 |
| Levothyroxine Sodium | 43 | $537 |
| Atorvastatin Calcium | 45 | $430 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $414 |
| Gabapentin | 20 | $305 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $241 |
| Amlodipine Besylate | 58 | $220 |
| Losartan Potassium | 22 | $189 |
| Lisinopril | 39 | $162 |
| Doxycycline Hyclate | 25 | $161 |
| Fluticasone Propionate | 15 | $116 |
| Tamsulosin Hcl | 12 | $113 |
| Metoprolol Tartrate | 16 | $95 |
| Simvastatin | 12 | $92 |
| Trazodone Hcl | 13 | $92 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Alexandria
- Lauren FerrisRoanoke$11K
- Catherine RatliffCharlottesville$10K
- Jennifer TaylorAbingdon$9K
- Alexander KingCharlottesville$7K
- Margaret HeidenreichChantilly$6K
- Jillian MaurielloRichmond$6K
- Christine HowellNorfolk$6K
- Molly McCrackenRichmond$5K
- Meredith OverstreetManassas$5K
- Danielle JenningsRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.